Skip to main content

Advertisement

Log in

Clinical Outcomes and Costs Associated with In-hospital Biliary Complications After Liver Transplantation: a Cross-Sectional Analysis

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Introduction

In-hospital biliary complications (BCs) after liver transplantation (LT) are reported in up to 20 % of patients and contribute to poor outcomes and increased costs. Existing single-center outcome and cost analyses studies are limited in scope.

Methods

This is a cross-sectional analysis of national data involving 7,967 patients transplanted between 2011 and 2012 with the primary aim of determining the association between BCs and clinical outcomes and costs. Age, race, diagnosis, and severity of illness are associated with the development of BCs.

Results

BCs develop in 14.6 % of LT recipients and have substantial implications for perioperative outcomes, including length of hospital and ICU stay (27.9 vs 19.6 mean days, p < 0.001 and 12.0 vs 8.3 mean days, p < 0.001, respectively), in-hospital morbidity (39 vs 27 %, p < 0.001), 30-day readmissions (14.8 vs 11.2 %, p < 0.001), and in-hospital mortality (5.8 vs 4.0 %, p < 0.001). BCs contributed to a mean increase in in-hospital costs of $36,212 (p < 0.001), due to increases in accommodations ($9,539, p < 0.001), surgical services ($3,988, p < 0.001), and pharmacy services ($8,445, p < 0.001).

Discussion

BCs are a predominant etiology for in-hospital morbidity and mortality, while contributing significantly to the high cost of LT. Efforts should be focused on understanding salient and modifiable risk factors, while developing innovative strategies to reduce BCs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

BCs:

Biliary complications

LT:

Liver transplantation

DCD:

Donation after cardiac death

UHC:

University HealthSystem Consortium

ICU:

Intensive care unit

LOS:

Length of stay

GI:

Gastrointestinal

NEC:

Not elsewhere classified

NOS:

Not otherwise specified

ICD-9:

International Statistical Classification of Diseases and Related Health Problems

US:

United States

References

  1. Colonna JO, 2nd, Shaked A, Gomes AS, Colquhoun SD, Jurim O, McDiarmid SV, et al. Biliary strictures complicating liver transplantation. Incidence, pathogenesis, management, and outcome. Ann Surg. 1992;216(3):344–50; discussion 50–2.

  2. Heidenhain C, Heise M, Jonas S, Ben-Asseur M, Puhl G, Mittler J, et al. Retrograde reperfusion via vena cava lowers the risk of initial nonfunction but increases the risk of ischemic-type biliary lesions in liver transplantation—a randomized clinical trial. Transpl Int. 2006;19(9):738–48.

    Article  PubMed  Google Scholar 

  3. Neuhaus P, Blumhardt G, Bechstein WO, Steffen R, Platz KP, Keck H. Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants. Ann Surg. 1994;219(4):426–34.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  4. Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Wahlstrom HE, Moore SB, et al. Ischemic-type biliary complications after orthotopic liver transplantation. Hepatology. 1992;16(1):49–53.

    Article  CAS  PubMed  Google Scholar 

  5. Adam R, Bismuth H, Diamond T, Ducot B, Morino M, Astarcioglu I, et al. Effect of extended cold ischaemia with UW solution on graft function after liver transplantation. Lancet. 1992;340(8832):1373–6.

    Article  CAS  PubMed  Google Scholar 

  6. Qian YB, Liu CL, Lo CM, Fan ST. Risk factors for biliary complications after liver transplantation. Arch Surg. 2004;139(10):1101–5.

    Article  PubMed  Google Scholar 

  7. Azoulay D, Castaing D, Adam R, Savier E, Delvart V, Karam V, et al. Split-liver transplantation for two adult recipients: feasibility and long-term outcomes. Ann Surg. 2001;233(4):565–74.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Lallier M, St-Vil D, Luks FI, Laberge JM, Bensoussan AL, Guttman FM, et al. Biliary tract complications in pediatric orthotopic liver transplantation. J Pediatr Surg. 1993;28(9):1102–5.

    Article  CAS  PubMed  Google Scholar 

  9. Martelius T, Krogerus L, Hockerstedt K, Bruggeman C, Lautenschlager I. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts. Hepatology. 1998;27(4):996–1002.

    Article  CAS  PubMed  Google Scholar 

  10. Moser MA, Wall WJ. Management of biliary problems after liver transplantation. Liver Transpl. 2001;7(11 Suppl 1):S46-52.

    Article  CAS  PubMed  Google Scholar 

  11. Baccarani U, Isola M, Adani GL, Avellini C, Lorenzin D, Rossetto A, et al. Steatosis of the hepatic graft as a risk factor for post-transplant biliary complications. Clin Transplant. 2010;24(5):631–5.

    Article  PubMed  Google Scholar 

  12. Evans RW, Manninen DL, Dong FB. An economic analysis of liver transplantation. Costs, insurance coverage, and reimbursement. Gastroenterol Clin North Am. 1993;22(2):451–73.

    CAS  PubMed  Google Scholar 

  13. Engelhardt HT, Jr. Shattuck lecture—allocating scarce medical resources and the availability of organ transplantation. Some moral presuppositions. N Engl J Med. 1984;311(1):66–71.

    Article  PubMed  Google Scholar 

  14. Sanchez-Urdazpal L, Gores GJ, Ward EM, Maus TP, Buckel EG, Steers JL, et al. Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation. Hepatology. 1993;17(4):605–9.

    Article  CAS  PubMed  Google Scholar 

  15. Kiuchi T, Ishiko T, Nakamura T, Egawa H, Uemoto S, Inomata Y, et al. Duct-to-duct biliary reconstruction in living donor liver transplantation. Transplant Proc. 2001;33(1–2):1320–1.

    Article  CAS  PubMed  Google Scholar 

  16. Englesbe MJ, Dimick J, Mathur A, Ads Y, Welling TH, Pelletier SJ, et al. Who pays for biliary complications following liver transplant? A business case for quality improvement. Am J Transplant. 2006;6(12):2978–82.

    Article  CAS  PubMed  Google Scholar 

  17. Kling K, Lau H, Colombani P. Biliary complications of living related pediatric liver transplant patients. Pediatr Transplant. 2004;8(2):178–84.

    Article  PubMed  Google Scholar 

  18. Gunawansa N, McCall JL, Holden A, Plank L, Munn SR. Biliary complications following orthotopic liver transplantation: a 10-year audit. HPB (Oxford). 2011;13(6):391–9.

    Article  Google Scholar 

  19. Fan ST, Lo CM, Liu CL, Tso WK, Wong J. Biliary reconstruction and complications of right lobe live donor liver transplantation. Ann Surg. 2002;236(5):676–83.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Heidenhain C, Pratschke J, Puhl G, Neumann U, Pascher A, Veltzke-Schlieker W, et al. Incidence of and risk factors for ischemic-type biliary lesions following orthotopic liver transplantation. Transpl Int. 2010;23(1):14–22.

    Article  PubMed  Google Scholar 

  21. Moench C, Moench K, Lohse AW, Thies J, Otto G. Prevention of ischemic-type biliary lesions by arterial back-table pressure perfusion. Liver Transpl. 2003;9(3):285–9.

    Article  PubMed  Google Scholar 

  22. Theruvath TP, Zhong Z, Pediaditakis P, Ramshesh VK, Currin RT, Tikunov A, et al. Minocycline and N-methyl-4-isoleucine cyclosporin (NIM811) mitigate storage/reperfusion injury after rat liver transplantation through suppression of the mitochondrial permeability transition. Hepatology. 2008;47(1):236–46.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Kato H, Amersi F, Buelow R, Melinek J, Coito AJ, Ke B, et al. Heme oxygenase-1 overexpression protects rat livers from ischemia/reperfusion injury with extended cold preservation. Am J Transplant. 2001;1(2):121–8.

    Article  CAS  PubMed  Google Scholar 

  24. Chavin KD, Taber DJ, Norcross M, Pilch NA, Crego H, McGillicuddy JW, et al. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm. Clin Transplant. 2013;27(5):732–41.

    PubMed  Google Scholar 

  25. Nativ NI, Maguire TJ, Yarmush G, Brasaemle DL, Henry SD, Guarrera JV, et al. Liver defatting: an alternative approach to enable steatotic liver transplantation. Am J Transplant. 2012;12(12):3176–83.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  26. Marty FM, Winston DJ, Rowley SD, Vance E, Papanicolaou GA, Mullane KM, et al. CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation. N Engl J Med. 2013;369(13):1227–36.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

No extramural funding source associated with this study.

Conflict of Interest

No authors have any competing interests. An ethics statement was not required for this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Arun P. Palanisamy.

Additional information

Arun P. Palanisamy and D. J. Taber contributed equally to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Palanisamy, A.P., Taber, D.J., Sutter, A.G. et al. Clinical Outcomes and Costs Associated with In-hospital Biliary Complications After Liver Transplantation: a Cross-Sectional Analysis. J Gastrointest Surg 19, 282–289 (2015). https://doi.org/10.1007/s11605-014-2675-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-014-2675-1

Keywords

Navigation